IDiyas

For the Inventor, By the Inventor

Orsay, France

Daniel C Obitz

USPTO Granted Patents = 14

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 99(Granted Patents)


Location History:

  • Orsay, FR (1977 - 1981)
  • Fontenay aux Roses, FR (1990 - 1991)
  • Antony, FR (1984 - 1996)

Company Filing History:

goldMedal14 out of 252 
 
Synthelabo
 patents

Years Active: 1977-1996

Loading Chart...
14 patents (USPTO):Explore Patents
1. 5530002 - 1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives, their (1996-06-25),
2. 5192763 - [(1-arylpyrrolidin-2-yl)methyl]piperazine derivatives, their preparation (1993-03-09),
3. 5010079 - Indolone derivatives, their preparation and their application in therapy (1991-04-23),
4. 4983607 - Quinolinone derivatives and their preparation in therapy (1991-01-08),
5. 4963680 - Piperazine derivatives and their preparation process (1990-10-16),
6. 4950670 - 6-phenyl-3-(piperazinyalalkyl)-2,4(1H,3H)-pyrimidinedione derivatives, (1990-08-21),
7. 4711892 - Certain 5-nitro-2-furyl derivatives of pyridylpropenoic acid hydrazides (1987-12-08),
8. 4530843 - Isoindole amidoxime derivatives (1985-07-23),
9. 4438121 - Isoquinoline amidoxime derivatives (1984-03-20),
10. 4265911 - Propionamidoxime derivatives (1981-05-05),
11. 4189495 - 2-Methoxy-benzamide derivatives (1980-02-19),
12. 4172143 - 2-Methoxy-benzamide derivatives (1979-10-23),
13. 4158060 - 2-Methoxy-benzamide derivatives (1979-06-12),
14. 4021567 - 2-Methoxy-benzamide derivatives (1977-05-03),

Title: The Innovative Contributions of Daniel C. Obitz

Introduction

Daniel C. Obitz is a prominent inventor based in Orsay, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of neurological disorders. With a total of 14 patents to his name, Obitz has established himself as a key figure in innovation.

Latest Patents

Among his latest patents, Obitz has developed compounds such as 1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives. These compounds are characterized by a formula where X represents a hydrogen atom, a C1-C3 alkoxy group, or a cyclopropylmethoxy group, and Y represents a hydrogen atom or a methoxy group. These compounds are useful in the therapy of various conditions. Another notable patent includes [(1-arylpyrrolidin-2-yl)methyl]piperazine derivatives, which correspond to a specific formula involving a group of formula N-R1. This innovation is aimed at treating neurological disorders and showcases Obitz's commitment to advancing medical science.

Career Highlights

Daniel C. Obitz is currently associated with Synthelabo, a company known for its focus on pharmaceutical research and development. His work at Synthelabo has allowed him to explore and innovate in the field of medicinal chemistry, leading to the creation of valuable therapeutic compounds.

Collaborations

Obitz has collaborated with notable colleagues such as Philippe Michel Manoury and Henry Najer. These partnerships have contributed to the successful development of his patented compounds and have fostered a collaborative environment for innovation.

Conclusion

Daniel C. Obitz's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact the treatment of neurological disorders, showcasing the vital role of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…